KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Gross Profit (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Gross Profit for 11 consecutive years, with $205.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 15.14% year-over-year to $205.3 million, compared with a TTM value of $706.5 million through Dec 2025, up 7.64%, and an annual FY2025 reading of $760.6 million, up 15.89% over the prior year.
  • Gross Profit was $205.3 million for Q4 2025 at Medpace Holdings, up from $178.3 million in the prior quarter.
  • Across five years, Gross Profit topped out at $205.3 million in Q4 2025 and bottomed at $74.7 million in Q2 2021.
  • Average Gross Profit over 5 years is $126.3 million, with a median of $124.3 million recorded in 2023.
  • The sharpest move saw Gross Profit rose 6.19% in 2021, then soared 36.67% in 2022.
  • Year by year, Gross Profit stood at $88.0 million in 2021, then skyrocketed by 31.54% to $115.7 million in 2022, then grew by 18.21% to $136.8 million in 2023, then skyrocketed by 30.34% to $178.3 million in 2024, then rose by 15.14% to $205.3 million in 2025.
  • Business Quant data shows Gross Profit for MEDP at $205.3 million in Q4 2025, $178.3 million in Q4 2024, and $169.0 million in Q3 2024.